| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
103 |
| issn |
1177-5475 |
| issueIdentifier |
2 |
| pageRange |
93-103 |
| publicationName |
Biologics : targets & therapy |
| startingPage |
93 |
| bibliographicCitation |
Vena GA, Cassano N. Drug focus: adalimumab in the treatment of moderate to severe psoriasis. Biologics. 2007 Jun;1(2):93–103. PMID: 19707319; PMCID: PMC2721299. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd87ae4e92a0b462a280c1f3b1a1195f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a536b9600ddae2547f3b3f0c724eced7 |
| date |
200706 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC2721299
https://pubmed.ncbi.nlm.nih.gov/19707319 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36005
https://portal.issn.org/resource/ISSN/1177-5475 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Drug focus: adalimumab in the treatment of moderate to severe psoriasis |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7365
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ab9bc7ce433266ca5b4543e538aeed73
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9287
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9007
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9751 |